Variant report

Variant	nsv3336
Chromosome Location	chr20:23804081-23848943
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:132)
CpG islands
(count:305)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:132 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr20:23832673-23832794	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr20:23828412-23828599	HepG2	liver:	n/a	chr20:23828517-23828526 chr20:23828517-23828528 chr20:23828515-23828526 chr20:23828517-23828526 chr20:23828517-23828526 chr20:23828517-23828526 chr20:23828515-23828528
3	CEBPB	chr20:23828408-23828598	A549	lung:	n/a	chr20:23828517-23828526 chr20:23828517-23828528 chr20:23828515-23828526 chr20:23828517-23828526 chr20:23828517-23828526 chr20:23828517-23828526 chr20:23828515-23828528
4	CEBPB	chr20:23847533-23847686	A549	lung:	n/a	n/a
5	CEBPB	chr20:23847524-23847664	HepG2	liver:	n/a	n/a
6	CTCF	chr20:23805840-23805990	HEK293	kidney:	n/a	n/a
7	CTCF	chr20:23816560-23816710	HBMEC	blood vessel:	n/a	n/a
8	CTCF	chr20:23805957-23806035	MCF-7	breast:	n/a	n/a
9	CTCF	chr20:23806035-23806099	GM13976	blood:	n/a	n/a
10	CTCF	chr20:23826257-23826361	K562	blood:	n/a	n/a
11	CTCF	chr20:23805971-23806035	MCF-7	breast:	n/a	n/a
12	CTCF	chr20:23837519-23837715	MCF-7	breast:	n/a	n/a
13	CTCF	chr20:23826266-23826336	K562	blood:	n/a	n/a
14	CTCF	chr20:23826220-23826370	HEK293	kidney:	n/a	n/a
15	CTCF	chr20:23837540-23837709	MCF-7	breast:	n/a	n/a
16	CTCF	chr20:23826180-23826330	MCF-7	breast:	n/a	n/a
17	CTCF	chr20:23832042-23832099	GM20000	blood:	n/a	n/a
18	CTCF	chr20:23826175-23826396	Gliobla	brain:	n/a	n/a
19	CTCF	chr20:23805983-23806110	LNCaP	prostate:	n/a	n/a
20	CTCF	chr20:23805758-23805774	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr20:23826201-23826203	MCF-7	breast:	n/a	n/a
22	CTCF	chr20:23822953-23822998	GM10266	blood:	n/a	n/a
23	CTCF	chr20:23805040-23805190	GM12866	blood:	n/a	n/a
24	CTCF	chr20:23805840-23805990	HBMEC	blood vessel:	n/a	n/a
25	CTCF	chr20:23826250-23826323	MCF-7	breast:	n/a	n/a
26	CTCF	chr20:23810371-23810443	GM13976	blood:	n/a	n/a
27	CTCF	chr20:23805800-23805950	HEK293	kidney:	n/a	n/a
28	CTCF	chr20:23826180-23826330	HepG2	liver:	n/a	n/a
29	CTCF	chr20:23837500-23837650	MCF-7	breast:	n/a	n/a
30	CTCF	chr20:23826231-23826342	HepG2	liver:	n/a	n/a
31	CTCF	chr20:23826200-23826350	HCT-116	colon:	n/a	n/a
32	CTCF	chr20:23823800-23823950	GM12874	blood:	n/a	n/a
33	CTCF	chr20:23837521-23837711	MCF-7	breast:	n/a	n/a
34	CTCF	chr20:23805840-23805990	SK-N-SH_RA	brain:	n/a	n/a
35	CTCF	chr20:23837530-23837701	NHEK	skin:	n/a	n/a
36	CTCF	chr20:23832700-23832850	GM12867	blood:	n/a	n/a
37	CTCF	chr20:23826207-23826394	MCF-7	breast:	n/a	n/a
38	CTCF	chr20:23826205-23826376	MCF-7	breast:	n/a	n/a
39	CTCF	chr20:23828860-23828892	Fibrobl	skin:	n/a	n/a
40	CTCF	chr20:23837515-23837733	MCF-7	breast:	n/a	n/a
41	CTCF	chr20:23832056-23832136	GM13976	blood:	n/a	n/a
42	CTCF	chr20:23805840-23805990	GM12874	blood:	n/a	n/a
43	CTCF	chr20:23837500-23837650	NHEK	skin:	n/a	n/a
44	CTCF	chr20:23805860-23806010	GM12870	blood:	n/a	n/a
45	CTCF	chr20:23805840-23806099	K562	blood:	n/a	n/a
46	CTCF	chr20:23816563-23816657	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr20:23826202-23826374	LNCaP	prostate:	n/a	n/a
48	CTCF	chr20:23837480-23837630	MCF-7	breast:	n/a	n/a
49	CTCF	chr20:23805880-23806030	GM12873	blood:	n/a	n/a
50	CTCF	chr20:23826271-23826333	Medullo	brain:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:23806999-23807049	AG10803	skin:	n/a
2	chr20:23807778-23807828	NHBE	bronchial:	n/a
3	chr20:23807736-23807786	MCF-7	breast:	n/a
4	chr20:23807359-23807409	HL-60	blood:	n/a
5	chr20:23807736-23807786	PrEC	prostate:	n/a
6	chr20:23807736-23807786	HEK293	kidney:	embryo
7	chr20:23806999-23807049	LNCaP	prostate:	n/a
8	chr20:23807736-23807786	AG04449	skin:	fetal
9	chr20:23807306-23807356	Caco-2	colon:	n/a
10	chr20:23807736-23807786	HepG2	liver:	n/a
11	chr20:23806999-23807049	AG04450	lung:	fetal
12	chr20:23807306-23807356	PANC-1	pancreas:	n/a
13	chr20:23807306-23807356	HPAEpiC	pulmonary alveolar:	n/a
14	chr20:23807306-23807356	NB4	blood:	n/a
15	chr20:23807306-23807356	AG09309	skin:	n/a
16	chr20:23807778-23807828	HCM	heart:	n/a
17	chr20:23807778-23807828	HL-60	blood:	n/a
18	chr20:23807306-23807356	HCT-116	colon:	n/a
19	chr20:23806999-23807049	PrEC	prostate:	n/a
20	chr20:23807306-23807356	GM12878	blood:	n/a
21	chr20:23807306-23807356	K562	blood:	n/a
22	chr20:23806999-23807049	HMEC	breast:	n/a
23	chr20:23807736-23807786	K562	blood:	n/a
24	chr20:23807778-23807828	AG09319	gingival:	n/a
25	chr20:23806999-23807049	GM12891	blood:	n/a
26	chr20:23807778-23807828	H1-hESC	embryonic stem cell:	embryo
27	chr20:23807359-23807409	AG04450	lung:	fetal
28	chr20:23807359-23807409	Hela-S3	cervix:	n/a
29	chr20:23806999-23807049	H1-hESC	embryonic stem cell:	embryo
30	chr20:23806999-23807049	NHBE	bronchial:	n/a
31	chr20:23807778-23807828	GM12892	blood:	n/a
32	chr20:23807736-23807786	AG09309	skin:	n/a
33	chr20:23807778-23807828	PFSK-1	brain:	n/a
34	chr20:23806999-23807049	HAEpiC	amniotic membrane:	n/a
35	chr20:23807778-23807828	ovcar-3	ovarian:	n/a
36	chr20:23807736-23807786	AG09319	gingival:	n/a
37	chr20:23807778-23807828	HCPEpiC	choroid plexus:	n/a
38	chr20:23806999-23807049	BE2_C	brain:	n/a
39	chr20:23806999-23807049	Caco-2	colon:	n/a
40	chr20:23807359-23807409	GM12892	blood:	n/a
41	chr20:23807306-23807356	RPTEC	kidney:	n/a
42	chr20:23807736-23807786	BJ	skin:	n/a
43	chr20:23807778-23807828	Hepatocyte	liver:	n/a
44	chr20:23807359-23807409	A549	lung:	n/a
45	chr20:23807359-23807409	HMEC	breast:	n/a
46	chr20:23807306-23807356	LNCaP	prostate:	n/a
47	chr20:23807736-23807786	GM06990	blood:	n/a
48	chr20:23807306-23807356	HMEC	breast:	n/a
49	chr20:23807359-23807409	U87	brain:	n/a
50	chr20:23806999-23807049	ovcar-3	ovarian:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr20:23779275..23780409-chr20:23837370..23837992,3	MCF-7	breast:
2	chr20:23648665..23649293-chr20:23837547..23838405,2	MCF-7	breast:
3	chr20:23754506..23755505-chr20:23837367..23838288,3	MCF-7	breast:

No data

Variant related genes	Relation type
CST2	TF binding region
CST2	CpG island

Extended variants
information (count: 1827 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:1827 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs78140743	chr20:23804104-23804105	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs537284839	chr20:23804105-23804106	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs150615439	chr20:23804133-23804134	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs568448817	chr20:23804177-23804178	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs71338684	chr20:23804178-23804179	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs570987569	chr20:23804188-23804189	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs189446174	chr20:23804209-23804210	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs554010132	chr20:23804221-23804222	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs577031559	chr20:23804242-23804243	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs139718610	chr20:23804243-23804244	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs556427936	chr20:23804259-23804260	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs41309345	chr20:23804265-23804266	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs541891307	chr20:23804272-23804273	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs111536107	chr20:23804296-23804297	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs572441898	chr20:23804317-23804318	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs149768780	chr20:23804328-23804329	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs6138123	chr20:23804355-23804356	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs181720820	chr20:23804361-23804362	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs147913268	chr20:23804367-23804368	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs562486150	chr20:23804374-23804375	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs531421551	chr20:23804375-23804376	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs184461622	chr20:23804384-23804385	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs117441059	chr20:23804393-23804394	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs116433552	chr20:23804413-23804414	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs535776349	chr20:23804433-23804434	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs570805415	chr20:23804438-23804439	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs557681007	chr20:23804440-23804441	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs539684605	chr20:23804519-23804520	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs146315351	chr20:23804557-23804558	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs556699202	chr20:23804570-23804571	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs576486721	chr20:23804577-23804578	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs535965217	chr20:23804583-23804584	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs555547706	chr20:23804595-23804596	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs572484041	chr20:23804610-23804611	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs541393635	chr20:23804611-23804612	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs374281628	chr20:23804612-23804613	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs115899654	chr20:23804622-23804623	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs114591498	chr20:23804625-23804626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs188785291	chr20:23804628-23804629	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs377520834	chr20:23804633-23804634	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs370913078	chr20:23804640-23804641	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs562682128	chr20:23804641-23804642	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs374244859	chr20:23804646-23804647	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs368501503	chr20:23804648-23804649	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs113175529	chr20:23804654-23804655	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs375585513	chr20:23804661-23804662	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs139220979	chr20:23804662-23804663	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs76198093	chr20:23804663-23804664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs546978671	chr20:23804684-23804685	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs202150666	chr20:23804691-23804692	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
small cell lung cancer	17426248	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:199 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23801400-23806800	Enhancers	Fetal Thymus	thymus
2	chr20:23802000-23806800	Weak transcription	NHDF-Ad	bronchial
3	chr20:23803800-23804200	Enhancers	Stomach Smooth Muscle	stomach
4	chr20:23803800-23805400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr20:23804000-23804200	Enhancers	Brain Anterior Caudate	brain
6	chr20:23804000-23804200	Enhancers	Brain Inferior Temporal Lobe	brain
7	chr20:23804000-23804400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr20:23804000-23804400	Bivalent Enhancer	Fetal Stomach	stomach
9	chr20:23804000-23804600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr20:23804000-23804600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr20:23804000-23804600	Enhancers	Duodenum Smooth Muscle	Duodenum
12	chr20:23804000-23804600	Enhancers	Fetal Muscle Trunk	muscle
13	chr20:23804000-23804800	Enhancers	Dnd41	blood
14	chr20:23804000-23805000	Enhancers	Fetal Muscle Leg	muscle
15	chr20:23804000-23805000	Enhancers	Lung	lung
16	chr20:23804200-23804400	Flanking Active TSS	Stomach Smooth Muscle	stomach
17	chr20:23804200-23804600	Enhancers	H1 Cell Line	embryonic stem cell
18	chr20:23804200-23804600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr20:23804200-23804800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
20	chr20:23804400-23805200	Enhancers	Fetal Stomach	stomach
21	chr20:23804400-23807400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr20:23804600-23806400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr20:23804600-23806800	Weak transcription	H1 Cell Line	embryonic stem cell
24	chr20:23804600-23806800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr20:23804800-23805200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr20:23804800-23807400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr20:23805000-23806800	Weak transcription	Fetal Muscle Leg	muscle
28	chr20:23805200-23805400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
29	chr20:23805400-23806400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr20:23805400-23807000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
31	chr20:23806400-23807600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr20:23806400-23807800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr20:23806400-23807800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr20:23806600-23807400	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr20:23806600-23807400	Enhancers	NHLF	lung
36	chr20:23806600-23807800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr20:23806800-23807400	Enhancers	H1 Cell Line	embryonic stem cell
38	chr20:23806800-23807400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr20:23806800-23807400	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr20:23806800-23807400	Enhancers	Fetal Muscle Leg	muscle
41	chr20:23806800-23807800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
42	chr20:23806800-23807800	Enhancers	NHDF-Ad	bronchial
43	chr20:23806800-23808000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr20:23806800-23808000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr20:23807000-23807400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
46	chr20:23807000-23807400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
47	chr20:23807000-23807400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr20:23807000-23807400	Enhancers	Fetal Muscle Trunk	muscle
49	chr20:23807200-23807400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr20:23807200-23807600	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links